Virax Biolabs Correlations

VRAX Stock

USD 0.16 0.02 14.29%

Current 90-days correlation between Virax Biolabs Group and Windtree Therapeutics is 0.08 (i.e., Very good diversification).The correlation coefficient ranges from -1 to +1 and quantifies how closely the stock co-moves with paired assets.

Virax Biolabs Market Linkage

Moderate diversification

The correlation between Virax Biolabs and Dow Jones is 0.38, which Macroaxis classifies as Moderate diversification for the selected horizon. The overlap area shows the portion of risk diversified away by holding both instruments together.

Virax Biolabs has a market cap of 1.18 M, an operating margin of -1063.49% for the last reported period, current ratio of 0.04. Sector concentration and correlation with existing positions affect diversification impact. Broader economic conditions can influence Virax Biolabs Group's company valuation - related indicators include signals in nation.

Moving together with Virax Stock

0.69	DRMA	Dermata Therapeutics	Pair Corr
0.65	VRTX	Vertex Pharmaceuticals	Pair Corr
0.8	ESPR	Esperion Therapeutics	Pair Corr
0.8	EBS	Emergent Biosolutions	Pair Corr
0.82	OPTI	OptiBiotix Health Plc	Pair Corr
0.9	63E	ONWARD MEDICAL BV	Pair Corr
0.78	XTLB	XTL Biopharmaceuticals	Pair Corr
0.77	GOSS	Gossamer Bio	Pair Corr
0.68	IPHA	Innate Pharma	Pair Corr
0.67	DMN	Diamyd Medical AB	Pair Corr

Moving Against Virax Stock

0.84	PH4	PATTIES FOODS	Pair Corr
0.58	FDMT	4D Molecular Therapeutics	Pair Corr
0.54	XAGE	Longevity Health Holdings	Pair Corr
0.49	PTN	Palatin Technologies	Pair Corr
0.38	JUMP	Leveljump Healthcare Corp Earnings Call This Week	Pair Corr
0.86	HURA	TuHURA Biosciences	Pair Corr
0.76	KALV	Kalvista Pharmaceuticals	Pair Corr
0.55	SLN	Silence Therapeutics PLC	Pair Corr
0.51	LRMR	Larimar Therapeutics	Pair Corr
0.46	KRRO	Frequency Therapeutics Downward Rally	Pair Corr
0.32	KYTX	Kyverna Therapeutics	Pair Corr

Related Correlations Analysis

	WINT	NCEL	MLEC	DRMA	GTBP	ATXI	NKGN	ARTL	XRTX	ELAB
WINT		0.34	-0.29	0.45	0.36	0.53	-0.31	-0.03	0.68	0.41	WINT
NCEL	0.34		0.0	-0.04	-0.13	0.23	-0.07	-0.52	0.34	-0.06	NCEL
MLEC	-0.29	0.0		-0.33	-0.22	-0.24	0.18	-0.34	-0.35	-0.24	MLEC
DRMA	0.45	-0.04	-0.33		0.89	-0.03	-0.2	0.04	0.57	0.86	DRMA
GTBP	0.36	-0.13	-0.22	0.89		-0.22	-0.16	-0.06	0.46	0.92	GTBP
ATXI	0.53	0.23	-0.24	-0.03	-0.22		-0.2	0.23	0.44	-0.15	ATXI
NKGN	-0.31	-0.07	0.18	-0.2	-0.16	-0.2		-0.04	-0.11	-0.27	NKGN
ARTL	-0.03	-0.52	-0.34	0.04	-0.06	0.23	-0.04		-0.03	-0.03	ARTL
XRTX	0.68	0.34	-0.35	0.57	0.46	0.44	-0.11	-0.03		0.53	XRTX
ELAB	0.41	-0.06	-0.24	0.86	0.92	-0.15	-0.27	-0.03	0.53		ELAB
	WINT	NCEL	MLEC	DRMA	GTBP	ATXI	NKGN	ARTL	XRTX	ELAB

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ELAB	+ 0.92	GTBP
GTBP	+ 0.89	DRMA
ELAB	+ 0.86	DRMA
XRTX	+ 0.68	WINT
XRTX	+ 0.57	DRMA
ATXI	+ 0.53	WINT

High negative correlations

ARTL	- 0.52	NCEL
XRTX	- 0.35	MLEC
ARTL	- 0.34	MLEC
DRMA	- 0.33	MLEC
NKGN	- 0.31	WINT
MLEC	- 0.29	WINT

Risk-Adjusted Indicators

Strong recent returns in Virax Stock do not always mean Virax Biolabs Company is outperforming peers on business quality. Risk-adjusted metrics help compare Virax Biolabs' efficiency and downside exposure against peers on a like-for-like basis. These indicators are quantitative in nature and measure volatility and risk-adjusted expected returns across different positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
WINT	12.00	3.21	0.00	0.64	0.00	0.00	100.00	-50.00	150.00
NCEL	4.73	1.22	0.28	0.98	3.73	-6.30	12.77	-6.47	26.87
MLEC	9.15	1.11	0.14	-1.13	7.60	-13.12	19.08	-13.19	92.00
DRMA	6.94	-0.21	0.00	-0.14	0.00	0.00	15.87	-13.87	80.83
GTBP	3.63	-0.94	0.00	8.10	0.00	0.00	7.25	-9.62	29.97
ATXI	10.72	1.61	0.08	-0.40	12.06	-20.24	28.57	-29.27	122.38
NKGN	19.68	6.41	0.16	-0.76	15.25	-87.59	16.67	-15.79	300.00
ARTL	11.31	1.91	0.20	-7.80	8.81	-18.83	16.87	-16.23	247.58
XRTX	4.95	0.22	0.03	0.71	6.35	-5.67	9.83	-10.67	49.20
ELAB	13.94	-0.25	0.00	-0.03	0.00	0.00	30.43	-32.87	192.87

Virax Biolabs Corporate Management

Tomasz George	Chief Officer	Profile
Joel Yeung	Accounting Manager	Profile
Cameron Shaw	COO Director	Profile
James Wang	Head Sourcing	Profile